The Guardian - Pharmaceutical Industry

JANUARY 16, 2024

Group will tackle potential restrictions to items such as medicine amid geopolitical and climate threats The government is setting up a critical imports council to help tackle potential restrictions in supplies to the UK of items such as medicine, minerals, food and semiconductors, amid rising geopolitical and climate threats.

69

69

STAT

JUNE 22, 2023

government asked a federal judge to overturn a recent case in which a jury decided that Gilead Sciences did not infringe on patents held by the Centers for Disease Control and Prevention for a pair of groundbreaking HIV pills. Moreover, the drug company insisted that it acted in good faith during its negotiations with the government.

88

88

STAT

MARCH 20, 2023

lawmaker wants the federal government to probe potential conflicts of interest held by members of a panel created to set dietary guidelines after learning one panelist was a paid consultant to a drug company that sells weight loss treatments. Continue to STAT+ to read the full story…

89

89

STAT

MAY 9, 2023

government over the rights to groundbreaking HIV prevention pills. The CDC helped fund academic research into HIV prevention that later formed the basis for the pills. The CDC helped fund academic research into HIV prevention that later formed the basis for the pills. Continue to STAT+ to read the full story…

85

85

STAT

NOVEMBER 4, 2022

Amid mounting concern over antibiotic resistance, a coalition of academics and advocacy groups is urging Congress not to pass legislation to reward drug companies for developing new treatments, because they argue the bill fails to require acceptable clinical trial standards and is tantamount to a giveaway to the pharmaceutical industry.

Pharmaceutical Companies 101

Pharmaceutical Companies Pharmaceutical Companies 101

STAT

AUGUST 16, 2023

government probe into a monkey-smuggling operation emanating from Cambodia has gone in a new direction as the U.S. government probe into a monkey-smuggling operation emanating from Cambodia has gone in a new direction as the U.S. Rise and shine, everyone. The middle of the week is upon us. Have heart, though. A U.S. A U.S.

Research Laboratories 83

Research Laboratories Documentation Pharmaceutical Companies Pharmaceutical Companies 83

STAT

MAY 10, 2023

government over the rights to groundbreaking HIV prevention pills , STAT writes. The   The agency helped fund academic research into HIV prevention that later formed the basis for the pills. government filed a patent infringement lawsuit against a pharmaceutical company. … A U.S.

Pharmaceutical Companies 86

Pharmaceutical Companies Pharmaceutical Companies 86

STAT

AUGUST 9, 2023

I was working in a heavily resourced academic institution. Prescription drug shortages across drug classes have been on the radar of our governing bodies for decades. It felt absurd that I couldn’t even appropriately administer medications, but I figured this was an emergency. But it was not an isolated incident.

Chemotherapy 87

Chemotherapy 87

pharmaphorum

OCTOBER 20, 2022

Chair of the BMA’s medical academic staff committee, Professor David Strain, said: “The worrying decrease in the number of clinical trials [PDF] in the UK in recent years is further evidence of the UK’s declining dominance as one of the world’s leaders in medical research.

Vaccines 52

Vaccines 52

Pharma Marketing Network

JULY 12, 2023

Here are a few tips for assessing the accuracy of pharmaceutical-sponsored health information online: ● Check the source: Make sure the information is coming from a reputable source, such as a government agency, academic institution, or nonprofit organization. The internet is a vast resource of information on health and wellness.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Hospital Pharmacy Europe

FEBRUARY 15, 2024

The General Pharmaceutical Council (GPhC) has announced the appointment of five new members to its governing council, including the group chief pharmacist at Barts Health NHS Trust. The trio will replace Jo Kember, Mark Hammond and Dr Arun Midha on the GPhC governing council.

Hospitals 52

Hospitals 52

Roots Analysis

FEBRUARY 26, 2024

Likewise, there are several other targets that have not yet been successfully drugged and researchers are making significant efforts to identify novel approaches to target them. Advances in drug discovery and development technologies / platforms have increased the likelihood of targeting a number of the aforementioned types of biological targets.

52

52

European Pharmaceutical Review

MARCH 6, 2023

This milestone follows the finalisation of Moderna’s ten-year strategic partnership with the UK government, announced in December 2022. The facility is part of a larger investment which will see Moderna working with academic and NHS partners across the UK, bringing research, clinical trials and skills development to many parts of the country.

Vaccines 85

Vaccines FDA 85

pharmaphorum

AUGUST 27, 2020

Despite the UK’s world class research output and the many start-ups successfully spinning out from its academic institutions, in recent years UK biotech companies have struggled to access the capital they need to scale up and make their mark on the industry. A world-class science and start-up ecosystem.

Vaccines 116

Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies 116

pharmaphorum

FEBRUARY 14, 2022

Moderna is reportedly in late-stage negotiations with the UK government that could result in a new research and manufacturing facility being set up in the biotech ‘golden triangle’ between London, Oxford and Cambridge. pic.twitter.com/hVRQayqaxJ. — Sajid Javid (@sajidjavid) February 10, 2022.

Vaccines 105

Vaccines 105

European Pharmaceutical Review

NOVEMBER 30, 2023

We have seen a growth out of more academic science establishment phases into more commercial phasing organisations. o find out about the current trends in cell and gene therapy manufacturing, EPR spoke to Cell and Gene Therapy Catapult (CGT Catapult)’s Chief Manufacturing Officer, Stephen Ward, and Chief Business Officer, Jeanette Evans.

Medical Schools 77

Medical Schools 77

pharmaphorum

DECEMBER 19, 2022

A collaboration between academic centres in the UK has won government funding for a digital approach to dysfunctional breathing or dyspnoea, a symptom that affects around 10% of the population. Correcting dyspnoea can lead to improvements in breathlessness, hyperventilation and dizziness.

145

145

pharmaphorum

DECEMBER 23, 2020

Meanwhile, new research from the Nuffield Trust and academics from the Universities of Oxford, Sheffield and Michigan warns of a “perilously uncertain” future facing the UK health sector at the end of the Brexit transition period. The South East will face disruption even if a deal is reached. Uncertain future.

Communication 128

Communication 128

Hospital Pharmacy Europe

OCTOBER 6, 2023

As well as setting out recommendations for pharmacists, FIP is calling on Governments and policymakers to utilise pharmacists’ expertise in all phases of disaster and emergency management from risk mitigation and readiness to response and recovery.

Hospitals 52

Hospitals Communication 52

pharmaphorum

AUGUST 7, 2020

It is part of a five-point plan by Pfizer launched in March that urged all pharma companies and biotechs to work together with government agencies and academic institutions to tackle the COVID-19 pandemic. Pfizer will provide contract manufacturing services at its facility in McPherson, Kansas, to supply the drug to Gilead.

Immunization 116

Immunization FDA 116

European Pharmaceutical Review

NOVEMBER 3, 2022

The collaboration will provide recommendations to over 60 governments committed to climate resilience and low carbon health systems at Minister of Health level. The SMI Health Systems Task Force also includes leaders from World Health Organization (WHO), UNICEF and academic and non-governmental organisations. “The

84

84

The FDA Law Blog

MARCH 6, 2024

His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceutical companies to CROs and academic researchers to patient advocacy organizations. HP&M is proud to have our professionals participating in these important events. On March 20-21, Counsel John W.M.

FDA 59

FDA Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

JULY 13, 2021

Faced with a looming mental health crisis, the UK government has been urged to invest in the digitisation of service provision across the NHS in England in a new report from think tank Future Care Capital.

Documentation 124

Documentation 124

pharmaphorum

FEBRUARY 1, 2022

Unlike academic strategies for boosting digital skills, existing staff members have to learn new skills around the requirements of existing roles. Alongside upskilling strategies, the UK Government has committed to supporting close collaboration between technology companies, academic institutions and life sciences.

52

52

Hospital Pharmacy Europe

FEBRUARY 16, 2024

The NextGen project will be delivered by a 21-member consortium of academic, clinical, technical and commercial partners from across Europe and the US, including the European Society for Cardiology, and led by University Medical Center (UMC) Utrecht and Queen Mary University of London.

Hospitals 52

Hospitals 52

pharmaphorum

JUNE 15, 2022

An elite faculty of speakers will present on crucial topics such as rigorous clinical trial data exchange, and guide discussion through vital non-clinical focus points such as IP and funding strategy – as well as cutting edge insights from the academic world. What’s new for 2022? Click here to find out more.

52

52

PQA

APRIL 14, 2023

Pharmacies, health plans, health care providers, pharmacy benefit managers, biopharmaceutical companies, technology vendors, government agencies, associations, health information technology organizations, and academic researchers are all represented. PQA’s multi-stakeholder gathering is unique.

52

52

pharmaphorum

MARCH 23, 2022

In a bid to maintain that position, the governments of all four UK nations have now pledged their support for the sectors’ industry players. Representatives from industry associations and the governments and NHS in all four UK nations will meet to discuss the future of the country’s genomics sector. Plans for a joint workshop.

71

71

pharmaphorum

JANUARY 14, 2022

One objective is to increase the number of larger, multinational trials – specifically in the academic setting – that can take advantage of the scale afforded by organisations across member states acting together.

Documentation 126

Documentation 126

Pharmaceutical Technology

MAY 31, 2023

The drug discovery initiative is an interdisciplinary academic effort to expedite early-stage drug development. In March 2023, a consortium led by the University of Sydney received A$2.5m ($1.68m) from the New South Wales (NSW) government to accelerate drug discovery and design using stem-cell-derived organoids.

Data Entry 59

Data Entry Compounding Pharmaceutical Companies Pharmaceutical Companies 59

NICE

AUGUST 16, 2022

If companies, academic groups or others preparing evidence submissions for NICE have used the EQ-5D-5L questionnaire to measure health-related quality of life, our methods state that this data should be ‘mapped’ onto the EQ-5D-3L value set. Valuation studies are challenging. Where can I find more information?

95

95

pharmaphorum

MARCH 17, 2021

Hopes that the UK government would step in to support charity-funded medical research were dashed when the sector received no mention in the Budget despite campaigns to secure additional support. So, when research is at risk, what are the potential consequences for patient care, the wider research community, and UK plc in general?

Patient Care 98

Patient Care Vaccines 98

pharmaphorum

NOVEMBER 13, 2020

Importantly, this partnership also produces a post-COVID blueprint for academic-Catapult collaboration to drive UK productivity. This combination of academic endeavour with industrial rigour is critical to produce assets that can be adopted by industry or funded by venture capital.

Packaging 52

Packaging 52

pharmaphorum

DECEMBER 24, 2021

Among the numerous speakers were panellists examining the role of technology and the private sector, the role and benefit to governments, and the role of the academic sector. Perspective of countries. The membership of the partnership spans the globe and includes 33 countries.

Communication 105

Communication 105

Hospital Pharmacy Europe

DECEMBER 19, 2023

Alongside this, COP28 saw finance announcements made by stakeholders including governments, development banks, multilateral institutions, philanthropies and non-governmental organisations to expand their investments in climate and health solutions. C climate benchmark within reach.

Hospitals 52

Hospitals 52

pharmaphorum

DECEMBER 22, 2021

A group of 15 digital health startups have joined a programme set up by the US federal government to address health inequality and mitigate the effects if the COVID-19 pandemic.

Vaccines 119

Vaccines 119

pharmaphorum

SEPTEMBER 17, 2020

The US National Institutes of Health has awarded seven contracts to companies and academic institutions to develop digital health solutions to help fight the COVID-19 pandemic. The seven projects include a platform analysing patient data from Evidation Health from sources such as wearables to detect COVID-19 and differentiate it from the flu.

Vaccines 88

Vaccines 88